Sharp Brains: Brain Fitness and Cognitive Health News

Neuroplasticity, Brain Fitness and Cognitive Health News

Icon

Sanofi Ventures leads $17M investment in Click Therapeutics, finalist @ 2017 Brainnovations Pitch Contest

___

Sanofi Backs Click Ther­a­peu­tics as Dig­i­tal Med­i­cines Gain Momen­tum (Xcon­o­my):

Drug mak­ers are mak­ing more bets on the nascent field of dig­i­tal med­i­cine. The lat­est exam­ple: Click Ther­a­peu­tics announced Mon­day that it grabbed a $17 mil­lion invest­ment led by Sanofi Ven­tures, the Cam­bridge, MA-based ven­ture cap­i­tal arm of the French phar­ma­ceu­ti­cal giant. Read the rest of this entry »

Three pioneers of neuroplasticity research discuss the present and future of rewiring the brain

neuroplasticity-A DISCUSSION WITH EVE MARDER, MICHAEL MERZENICH AND CARLA SHATZ (2016 KAVLI PRIZE IN NEUROSCIENCE):

Our view of the brain as some­thing con­stant­ly shaped by thought and expe­ri­ence is only a few decades old, yet it has pro­found­ly influ­enced how we teach and treat, raise our young and care for the old.

Eve Marder, Michael Merzenich and Car­la Shatz are three researchers who, in very dif­fer­ent ways, have revealed that the brain is high­ly change­able, or plas­tic. Read the rest of this entry »

Akili raises an additional $11.9M; brings Amgen, Merck, Pfizer and Shire to the digital medicine table

akili-game—–

Akili Adds Amgen Ven­tures and M Ven­tures* to Series B Financ­ing, Increas­ing Round to $42.4 Mil­lion (press release):

Akili Inter­ac­tive Labs, Inc. (“Akili”), a dig­i­tal med­i­cine com­pa­ny devel­op­ing nov­el, non-phar­ma­co­log­i­cal ther­a­peu­tics and diag­nos­tics for cog­ni­tive dis­or­ders, today announced an $11.9 mil­lion expan­sion of its recent Series B financ­ing. Read the rest of this entry »

Brain Damage, Therapeutics and the Blood-Brain Barrier

Blood-Brain Bar­ri­er Less Per­me­able in New­borns than Adults after Acute Stroke (press release):

The blood-brain bar­ri­er is selec­tive­ly per­me­able and blocks unwant­ed mol­e­cules from enter­ing into the brain. The selec­tiv­i­ty is achieved Read the rest of this entry »

About SharpBrains

As seen in The New York Times, The Wall Street Journal, BBC News, CNN, Reuters,  SharpBrains is an independent market research firm tracking how brain science can improve our health and our lives.

Search in our archives

Follow us and Engage via…

twitter_logo_header
RSS Feed

Watch All Recordings Now (40+ Speakers, 12+ Hours)

Enter Your Email to receive Sharp­Brains free, monthly eNewslet­ter:

Join more than 50,000 Sub­scribers and stay informed and engaged.